HK1255014A1 - 製備取代5,6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法 - Google Patents

製備取代5,6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法

Info

Publication number
HK1255014A1
HK1255014A1 HK18114135.7A HK18114135A HK1255014A1 HK 1255014 A1 HK1255014 A1 HK 1255014A1 HK 18114135 A HK18114135 A HK 18114135A HK 1255014 A1 HK1255014 A1 HK 1255014A1
Authority
HK
Hong Kong
Prior art keywords
phenylbenzo
isoquinolin
dihydro
amine
methods
Prior art date
Application number
HK18114135.7A
Other languages
English (en)
Inventor
Craig Bates
David P Reed
Jianmin Mao
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Publication of HK1255014A1 publication Critical patent/HK1255014A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK18114135.7A 2015-12-17 2018-11-06 製備取代5,6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法 HK1255014A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268758P 2015-12-17 2015-12-17
PCT/US2016/067161 WO2017106639A1 (en) 2015-12-17 2016-12-16 Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Publications (1)

Publication Number Publication Date
HK1255014A1 true HK1255014A1 (zh) 2019-08-02

Family

ID=59057623

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114135.7A HK1255014A1 (zh) 2015-12-17 2018-11-06 製備取代5,6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法

Country Status (16)

Country Link
US (4) US9834519B2 (zh)
EP (2) EP4015508A1 (zh)
JP (2) JP6940504B2 (zh)
KR (1) KR20180085814A (zh)
CN (2) CN114874149A (zh)
AU (2) AU2016369520B2 (zh)
BR (1) BR112018012325A2 (zh)
CA (1) CA3006077A1 (zh)
EA (1) EA201891431A1 (zh)
HK (1) HK1255014A1 (zh)
IL (1) IL259557A (zh)
MX (2) MX2020012771A (zh)
NZ (1) NZ742785A (zh)
SG (1) SG11201804601TA (zh)
TW (1) TWI748972B (zh)
WO (1) WO2017106639A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201804601TA (en) 2015-12-17 2018-07-30 Arqule Inc Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
IL259556B2 (en) * 2015-12-17 2023-09-01 Arqule Inc Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds
CN110669015A (zh) * 2018-07-03 2020-01-10 上海喀露蓝科技有限公司 一种fgfr抑制剂的制备方法
US10878412B2 (en) * 2019-05-13 2020-12-29 Truist Bank In-line verification of transactions
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO1998028281A1 (en) 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
US7786132B2 (en) * 2004-12-17 2010-08-31 Amgen Inc. Aminopyrimidine compounds and methods of use
WO2008083356A1 (en) 2006-12-29 2008-07-10 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
KR101714799B1 (ko) * 2008-12-30 2017-03-09 아르퀼 인코포레이티드 치환된 5,6-디히드로-6-페닐벤조[f]이소퀴놀린-2-아민 화합물
EP2643314B1 (en) 2010-11-25 2016-07-13 ratiopharm GmbH Novel salts and polymorphic forms of afatinib
US8815854B2 (en) * 2011-06-24 2014-08-26 Arqule, Inc. Substituted imidazopyridinyl compounds
SG11201607772WA (en) * 2014-03-31 2016-10-28 Debiopharm Int Sa Fgfr fusions
SG11201804601TA (en) * 2015-12-17 2018-07-30 Arqule Inc Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
IL259556B2 (en) 2015-12-17 2023-09-01 Arqule Inc Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds

Also Published As

Publication number Publication date
JP2018537495A (ja) 2018-12-20
AU2021202610A1 (en) 2021-05-27
JP6940504B2 (ja) 2021-09-29
CA3006077A1 (en) 2017-06-22
TW201733992A (zh) 2017-10-01
EA201891431A1 (ru) 2018-11-30
EP4015508A1 (en) 2022-06-22
SG11201804601TA (en) 2018-07-30
US20170174637A1 (en) 2017-06-22
WO2017106639A1 (en) 2017-06-22
CN114874149A (zh) 2022-08-09
JP2021191782A (ja) 2021-12-16
EP3390368A1 (en) 2018-10-24
CN108602779A (zh) 2018-09-28
NZ742785A (en) 2023-06-30
US10093632B2 (en) 2018-10-09
AU2016369520B2 (en) 2021-02-18
KR20180085814A (ko) 2018-07-27
US9834519B2 (en) 2017-12-05
AU2016369520A1 (en) 2018-06-07
IL259557A (en) 2018-07-31
MX2018007415A (es) 2018-11-09
TWI748972B (zh) 2021-12-11
US11279679B2 (en) 2022-03-22
AU2021202610B2 (en) 2022-06-02
US10766868B2 (en) 2020-09-08
EP3390368A4 (en) 2019-07-03
MX2020012771A (es) 2022-10-04
US20200102276A1 (en) 2020-04-02
BR112018012325A2 (pt) 2018-12-04
US20190241527A1 (en) 2019-08-08
US20180065937A1 (en) 2018-03-08

Similar Documents

Publication Publication Date Title
ZA201700019B (en) Substituted [1,2,4]triazole compounds
ZA201606844B (en) Method for preparing amg 416
HK1232210A1 (zh) 製備 -四氯丙烯的方法
IL246923A0 (en) A method for the production of (r)-3,1,1-trimethyl-4-aminoindan
IL250682A0 (en) A method for the preparation of 2'-o-fucosyl lactose
HK1255014A1 (zh) 製備取代5,6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法
HUE036789T2 (hu) Szintéziseljárás 1,2-benzizotiazolin-3-on elõállítására
HUE054626T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
PL3178803T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
SG11201803584RA (en) 1,4-dicarbonyl-piperidyl derivatives
HK1254800A1 (zh) 2,3,4,5-四氫吡啶-6-胺衍生物
GB2540428B (en) Process for preparing 3,3,3-trifluoropropene
ZA201903463B (en) Method for preparing hexadecahydropyrene
EP3201164A4 (en) Processes for preparing 2,5-dichlorophenol
PL3592723T3 (pl) Sposób wytwarzania 3,3,3-trifluoroprop-1-enu
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
IL253630B (en) A process for the preparation of modified phenylisoxazoline derivatives
TWI562978B (en) Method for preparation of 1,4-cyclohexanedialkanol